ABBOTT LABORATORIES
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
ABT$110.46-0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Financial Statements and Supplementary Data
| Page | |
|---|---|
| Consolidated Statement of Earnings | 41 |
| Consolidated Statement of Comprehensive Income | 42 |
| Consolidated Statement of Cash Flows | 43 |
| Consolidated Balance Sheet | 44 |
| Consolidated Statement of Shareholders’ Investment | 46 |
| Notes to Consolidated Financial Statements | 47 |
| Management Report on Internal Control Over Financial Reporting | 76 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 42) | 77 |
| Report of Independent Registered Public Accounting Firm | 92 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.